Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_6035_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •About the Editor
- •Contents
- •Contributors
- •Abbreviations
- •Preface
- •1. Natural Products as Drug Candidates
- •1.1 Introduction
- •1.2 An array of natural products
- •1.2.1 Plant-derived natural products
- •1.2.2 Microbial natural products
- •1.3 Importance of analytical techniques
- •1.3.1 A glance at extraction techniques
- •1.3.2 Microbial culturing techniques
- •1.3.3 Outlook and perspectives in nanoparticles
- •1.4 Natural products as a guide in drug design and synthesis
- •1.5 Natural products as promising drug candidates
- •1.5.1 Antiviral drug candidates
- •1.5.2 Antiparasitic drug candidates
- •1.5.3 Neuroprotective agents
- •1.6 Conclusion
- •Keywords
- •References
- •2. Traditional Knowledge for Drug Discovery
- •2.1 Introduction
- •2.2 Databases on indian remedial flora, indigenous medicines, and phytochemicals
- •2.2.1 Cultural preservation
- •2.2.2 Sustainable practices
- •2.2.3 Biodiversity conservation
- •2.2.4 Health and medicine
- •2.2.5 Climate change adaptation
- •2.2.6 Interconnectedness and wisdom
- •2.3 History of traditional knowledge
- •2.3.1 Indigenous healing practices
- •2.3.2 Aboriginal dreamtime
- •2.3.3 Traditional agriculture
- •2.3.4 Traditional crafts
- •2.3.5 Indigenous cosmologies
- •2.3.6 Traditional music and dance
- •2.3.7 Traditional navigation
- •2.4 Traditional medicine in plant formulations
- •2.4.1 Ayurveda
- •2.4.2 Traditional chinese medicine
- •2.4.3 Indigenous healing practices
- •2.5 Drug discovery
- •2.6 Aspects of developing plant-based drugs
- •2.6.1 Selection criteria for plants
- •2.6.2 Plant material authentication
- •2.6.3 Extraction methods
- •2.6.4 Isolation and structure elucidation of bioactive components
- •2.6.5 Standardization of plant formulations
- •2.7 Conclusions
- •References
- •3. Herbal Healing: Plant-Based Natural Products
- •3.1 Introduction
- •3.2 Classification of secondary metabolites
- •3.2.1 Phenolic compounds
- •3.2.2 Terpenes
- •3.2.3 Alkaloids
- •3.3 History of natural products
- •3.4 Drug discovery from natural products
- •3.5 Drugs derived from the plants
- •3.6 Conclusions
- •Keywords
- •References
- •4. Natural Products with Antimicrobial Properties
- •4.1 Introduction
- •4.2 Plants as antimicrobial agents
- •4.3 Marine sources as antimicrobial agents
- •4.4 Antimicrobial products derived from microorganisms
- •4.5 Conclusions and future trends
- •Keywords
- •References
- •5. Natural Products with Immunomodulatory Properties
- •5.1 Introduction
- •5.2.1 Aloe vera (l.) burm.f. (family: asphodelaceae)
- •5.2.2 Andrographis paniculata (burm. f.) wall.ex.nees. (family: acanthaceae)
- •5.2.3 Acorus calamus l. (family: araceae)
- •5.2.4 Allium sativum l. (family: alliaceae)
- •5.2.5 Azadirachta indica a. juss. (family: meliaceae)
- •5.2.6 Argyreia speciosa (l.f.) sweet (family: convolvulaceae)
- •5.2.7 Bidens pilosa l. (family: asteraceae)
- •5.2.8 Baliospermum montanum (willd.) müll.arg. (family: euphorbiaceae)
- •5.2.9 Boerhaavia diffusa l. (family: nyctaginaceae)
- •5.2.10 Boswellia serrata roxb. excolebr. (family: burseraceae)
- •5.2.11 Camellia sinensis (l.) kuntze (family: theaaceae)
- •5.2.12 Capparis zeylanica l. (family: capparidaceae)
- •5.2.13 Calendula officinalis l. (family: asteraceae)
- •5.2.14 Chelidonium majus l. (family: papaveraceae)
- •5.2.15 Carica papaya l. (family: caricaceae)
- •5.2.26 Glycyrrhiza glabra l. (family: leguminosae)
- •5.2.27 Hypericum perforatum l. (family: hypericaceae)
- •5.2.28 Hippophae rhamnoides l. (family: elaeagnaceae)
- •5.2.29 Hydrastis canadensis l. (family: ranunculaceae)
- •5.2.30 Jatropha curcas l. (family: euphorbiaceae)
- •5.2.31 Mangifera indica l. (family: anacardiaceae)
- •5.2.32 Mollugo verticillata l. (family: molluginaceae)
- •5.2.33 Matricaria chamomilla l. (family: asteraceae)
- •5.2.34 Momordica charantia l. (family: cucurbitaceae)
- •5.2.35 Morinda citrifolia l. (family: rubiaceae)
- •5.2.36 Nigella sativa l. (family: ranunculaceae)
- •5.2.37 Nelumbo nucifera gaertn. (family: nymphaeceae)
- •5.2.38 Nerium oleander l. (family: apocynaceae)
- •5.2.39 Ocimum tenuiflorum l. (family: labiatae)
- •5.2.40 Premna tomentosa willd. (family: verbanaceae)
- •5.2.41 Plantago sp. (plantago major l. and plantago asiatica l.) (family: plantaginaceae)
- •5.2.42 Psoralea corylifolia l. (family: fabaceae)
- •5.2.43 Prunella vulgaris l. (family: lamiaceae)
- •5.2.44 Punica granatum l. (family: punicaceae)
- •5.2.45 Rhinacanthus nasutus (l.) kurz (family: acanthaceae)
- •5.2.46 Salvia officinalis l. (family: lamiaceae)
- •5.2.47 Tamarindus indica l. (family: leguminosae)
- •5.2.48 Tinospora cordifolia (willd.) miers (family: menispermaceae)
- •5.2.16 Centella asiatica (l.) urb. (family: umbelliferae)
- •5.2.17 Cichorium intybus l. (family: asteraceae)
- •5.2.18 Cryptolepis dubia (burm.f.) m.r. almeida (family: apocynaceae)
- •5.2.19 Citrus aurantiifolia (christm.) swingle (family: rutaceae)
- •5.2.20 Curcuma longa l. (family: zingiberaceae)
- •5.2.21 Desmodium gangeticum (l.) dc. (family: fabaceae)
- •5.2.22 Eclipta prostrata (l.) (family: asteraceae)
- •5.2.23 Phyllanthus emblica l. (family: euphorbiaceae)
- •5.2.24 Evolvulus alsinoides (l.) (family: convolvulaceae)
- •5.2.25 Ficus benghalensis l. (family: moraceae)
- •5.2.49 Terminalia chebula retz. (family: combretaceae)
- •5.2.51 Urtica dioica l. (family: urticaceae)
- •5.2.52 Withania somnifera (l.) dunal (cultivated var.) (family: solanaceae)
- •5.3 Traditional importance of research to society and researchers
- •5.4 Conclusion
- •Keywords
- •References
- •6. Natural Products with Anticancerous Properties
- •6.1 Introduction
- •6.2 Plant-derived anticancer compounds
- •6.2.1 Polyphenols
- •6.2.2 Flavanoids
- •6.2.3 Brassinosteroids
- •6.2.4 Vinca alkaloids
- •6.2.5 Taxanes
- •6.2.6 Campothecin derivatives
- •6.3 Microorganisms-based anticancer compounds
- •6.3.1 Primary metabolites
- •6.3.2 Secondary metabolites
- •6.4 Selected medicinal plants with anticancerous activities
- •6.4.1 Curcuma longa l.
- •6.4.2 Viscum album l.
- •6.4.3 Colchicum autumnale l.
- •6.4.4 Raphanus sativus l.
- •6.4.5 Tinospora cordifolia wild
- •6.4.6 Nigella sativa l.
- •6.5 Therapeutic enzymes
- •6.6 Future perspective
- •6.7 Conclusion
- •Keywords
- •References
- •7. Natural Products with Antiviral Properties
- •7.1 Introduction
- •7.2 Source of natural products with antiviral activity
- •7.3 Main components of natural products
- •7.3.1 Flavonoids
- •7.3.2 Polyphenols
- •7.3.3 Polysaccharides
- •7.3.4 Terpenoids
- •7.4 Mechanisms of action of natural compounds in viral infections
- •7.4.1 Direct antiviral effect
- •7.4.2 Anti-inflammatory effect in viral infections
- •7.4.3 Effect on autophagy process
- •7.6 Conclusions
- •Keywords
- •References
- •8. Approaches to Develop Drugs from Natural Products
- •8.1 Introduction
- •8.2 Scenario of drug discovery
- •8.3 Efficient drug discovery engines
- •8.4 Drug discovery approaches using plants
- •8.4.1 Plant selection for screening purpose
- •8.4.2 Authentication of plants
- •8.4.3 Types of molecular markers
- •8.5.1 Parallel approach
- •8.5.2 Sequential approach
- •8.6 Structure elucidation of isolated compounds
- •8.7 Biological screening of extracts/fraction/isolates
- •8.7.1 Cell culture-based assay
- •8.7.2 Dialysis
- •8.7.3 Microdialysis
- •8.7.4 Ultrafiltration
- •8.7.5 Chromatography
- •8.7.6 Ligand fishing
- •8.8 Limitations
- •8.9 Molecular modelling and np database
- •8.10 Future thrust
- •8.11 Conclusion
- •Keywords
- •References
- •9. Strategies for Isolation and Identification of Bioactive Molecules from Natural Sources
- •9.1 Introduction
- •9.2 Bioactive compounds in natural sources and their pharmacological properties
- •9.3.1 Selection of materials
- •9.3.3 Types and properties of solvent for extraction
- •9.4 Extraction methods (conventional and modern)
- •9.4.1 Conventional methods
- •9.4.2 Novel extraction methods
- •9.5 Concentration and purification of bioactive molecules using chromatographic techniques
- •9.5.1 Separation based on adsorption properties
- •9.5.2 Separation based on partition coefficient
- •9.5.3 Separation based on the molecular size
- •9.5.4 Separation based on ionic strength
- •9.5.5 Other modern separation techniques
- •9.6 Identification and characterization of bioactive molecules
- •9.6.1 Qualitative and quantitative techniques/chromatographic or nonchromatographic techniques
- •9.7 Conclusions
- •Keywords
- •References
- •10. Role of Omics in Natural Product-Based Drug Discovery
- •10.1 Introduction
- •10.2 Genomics and transcriptomics in natural product discovery
- •10.2.1 Case studies and examples of natural product discovery using genomics and transcriptomics
- •10.2.2 Limitations and challenges of using genomics and transcriptomics in natural product discovery
- •10.3 Proteomics and metabolomics in natural product discovery
- •10.3.1 Case studies and examples of natural product discovery using proteomics and metabolomics
- •10.4 Bioinformatics in natural product-based drug discovery
- •10.4.1 Role of bioinformatics in natural product-based drug discovery
- •10.4.2 The use of bioinformatics to predict and annotate natural product biosynthetic pathways, gene clusters, and metabolomics
- •10.7 Future perspectives and potential impact of omics in natural product-based drug discovery
- •10.9 Potential impact on drug discovery and development
- •10.10 Conclusion
- •Keywords
- •References
- •11. Natural Products from Endophytic Microorganisms
- •11.1 Introduction
- •11.1.1 Rational/why endophytes?
- •11.2 Diversity of endophytic microorganisms
- •11.2.1 Endophytic bacteria and endophytic actinomycetes
- •11.2.2 Endophytic fungi
- •11.3.1 ISolation methods
- •11.3.1.1.1 Dilution Plating
- •11.3.1.1.2 Direct Plating
- •11.3.2 Identification methods
- •11.4 Bioactive compounds from endophytic microorganisms
- •11.4.1 Antibiotics
- •11.4.2 Antifungal agents
- •11.4.3 Antimalarial agents
- •11.4.4 Antiviral agents
- •11.4.5 Anticancer agents
- •11.4.6 Antioxidants
- •11.5 Stepwise methods for natural product discovery from endophytic microorganisms
- •11.5.1 Plant selection rationale
- •11.5.2 Isolation and cultivation of endophytes
- •11.5.3 Characterization of endophytes
- •11.5.4 Extraction of natural products
- •11.5.5 Purification of natural products
- •11.6 Biosynthesis and strategies for the optimization of natural product discovery from endophytic microorganisms
- •11.6.1 Exploration of novel microbial sources
- •11.6.2 Metabolomics-guided discovery
- •11.6.3 Coculture
- •11.6.4 Genome mining
- •11.6.5 Modulation by ultraviolent irradiation
- •11.7 Future directions and challenges
- •11.7.1 Improving the efficiency and accuracy of screening methods
- •11.7.2 Enhancing the scalability and affordability of production methods
- •11.7.3 Ensure natural product safety and efficacy
- •11.8 Conclusions
- •References
- •12. Natural Products with Antidiabetic Properties
- •12.1 Introduction
- •12.2 Natural products that regulate glucose absorption
- •12.2.1 Serotonin-derived products
- •12.2.2 Butyl-isobutyl-phthalate from laminaria japonica
- •12.2.3 Bioactive compounds of allium cepa and allium sativum
- •12.2.4 Elatosides E and F of aralia elata
- •12.2.5 Bioactive compounds of bauhinia candicans and bauhinia forficate
- •12.3 Natural products that enhance insulin sensitivity
- •12.3.1 Astragalus membranaceus polysaccharides
- •12.3.2 Bioactive compounds of litchi chinensis
- •12.3.3 Bioactive compounds of fenugreek
- •12.3.4 Bioactive compounds of cinnamon
- •12.3.5 Bioactive compounds of gastrodia elata
- •12.3.6 Polysaccharides of dioscorea
- •12.3.7 Anthocyanins of blueberries
- •12.3.8 Bioactive compounds of psidium guajava
- •12.4.1 Gingerol from zingiber officinale
- •12.4.2 Curcumin from curcuma longa
- •12.4.3 Berberine
- •12.4.4 Capsaicin of pepper
- •12.4.5 Bioactive compounds of bitter melon
- •12.4.6 Ginsenosides of ginseng
- •12.4.7 Bioactive compounds of aloe vera
- •12.4.8 Quinides of coffee
- •12.4.9 Bioactive compounds of tinospora cordifolia
- •12.4.10 Bioactive compounds of pterocarpus marsupium
- •12.4.11 Eugenol of ocimum sanctum
- •12.4.12 Bioactive compounds of syzygium densiflorum
- •12.5 Clinical trials based on antidiabetic effects of natural products derived from plants
- •12.5.1 Gymnema sylvestre (gurmar)
- •12.5.2 Fenugreek (trigonella foenum-graecum)
- •12.5.3 Tea catechins
- •12.5.4 Coffee
- •12.5.5 Rosemary (rosmarinus officinalis)
- •12.6 Conclusion
- •12.7 Future scope
- •Keywords
- •References
- •13. Marine-Derived Natural Products with Anticancer Properties
- •13.1 Introduction
- •13.2 Marine bioactive compounds
- •13.3 Anticancer activity of marine plants
- •13.4 Anticancer agents from marine floras
- •13.5.1 Antioxidants
- •13.5.2 Immunomodulation and apoptosis
- •13.5.3 Nutritional values and anticancer effects
- •13.6 Nature and cancer chemotherapy
- •13.7 Marine organisms and cancer chemotherapy
- •13.8 Anticancer agents from marine floras
- •13.9 Marine plants
- •13.9.1 Macro algae (seaweed)
- •13.9.2 Mangroves and other higher plants
- •13.9.3 Cyanobacteria
- •13.9.4 Bacteria
- •13.9.5 Proteobacteria
- •13.9.6 Cyanobacteria
- •13.9.7 Actinomycetes
- •13.9.8 Marine fungi
- •13.9.9 Soft corals
- •13.9.10 Marine sponges
- •13.10 Anticancer bioactive antibiotics derived from marine sources
- •13.10.1 Polyphenols
- •13.10.2 Polysaccharides
- •13.10.3 Alkaloids
- •13.11 Other marine sources for anticancer compounds
- •13.11.1 Peptides
- •13.11.2 Plitidepsin
- •13.11.3 Trabectedin
- •13.11.4 Lurbinectedin
- •13.12 Marine natural products as anticancer drugs
- •13.13.1 Aquaculture/cultivation
- •13.13.2 Genetic engineering
- •13.13.3 Synthesis/semisynthesis/modification
- •13.14 Conclusions and future prospects
- •References
- •14. Natural Products as Novel Opportunities for Cathepsin Inhibitors
- •14.1 Introduction
- •14.2 Cysteine proteases (CPs)
- •14.2.1 Cathepsin
- •14.2.2 Structure and mechanism of action of cathepsins
- •14.3 NPs as cathepsins inhibitors
- •14.3.1 NPs From bacteria as cathepsin inhibitors
- •14.3.2 NPs from fungus as cathepsin inhibitors
- •14.3.3 NPs from marine organism as cathepsin inhibitors
- •14.3.4 NPs from plants as cathepsin inhibitors
- •14.4 Conclusion and future pespectives
- •Keywords
- •References
- •15. Phytoestrogens in Drug Discovery: A Focus on Mechanisms of Action and Safety Assessment
- •15.1 Introduction
- •15.2 Phytoestrogens and estrogen receptors
- •15.3 Nonestrogen receptor-mediated effects of phytoestrogens
- •15.3.1 Mitogen-activated protein kinase (MAPK) pathway
- •15.3.2 PI3K/AKT pathway
- •15.3.3 WNT pathway
- •15.3.4 G-protein-coupled estrogen receptor (GPER)
- •15.4 Structure–activity relationship (SAR) of phytoestrogens
- •15.4.1 Isoflavones
- •15.4.2 Lignans
- •15.4.3 Coumestans
- •15.4.4 Stilbenes
- •15.4.5 Diarylheptanoids
- •15.5 Comparing potency and efficacy of phytoestrogens on various pathways
- •15.5.1 Potency and efficacy of phytoestrogens on different pathways
- •15.5.2 Possible synergistic effects of phytoestrogens with other drugs
- •15.6 Effects of phytoestrogens on the human organs
- •15.7 Safety Assessment of phytoestrogens
- •15.7.1 Toxicity assays used to evaluate the safety of phytoestrogens
- •15.7.2 Potential adverse effects of phytoestrogens
- •15.8 Case study
- •15.8.1 Vaginal cellular differentiation assay
- •15.8.2 Changes in rat body weight
- •15.8.3 Changes in rats’ uterus weight
- •15.9 Current trends in phytoestrogen research
- •15.9.1 Publication trends
- •15.9.2 Analysis of contributing countries and contributing institutions
- •15.9.3 Analysis of contributing publishers and journals
- •15.9.4 Publication evolution and research areas
- •15.9.5 Limitations
- •15.10 Future directions
- •15.10.1 Exploration of unexplored plant sources
- •15.10.2 Understanding mechanisms of action
- •15.10.3 Synthesis of novel compounds
- •15.10.4 Development of SPERMs
- •15.10.5 Safety assessment
- •15.11 Conclusion
- •Keywords
- •References
- •16. Honey Bee Products with Antimicrobial Properties
- •16.1 Introduction
- •16.2 Honey
- •16.3 Bee bread (perga)
- •16.4 Bee pollen
- •16.5 Bee propolis
- •16.6 Conclusion
- •Keywords
- •References
- •17. Natural Products for the Prevention of Leaky Gut
- •17.1 Introduction
- •17.2 The physical and chemical barriers of the intestine
- •17.2.1 Thick mucus layer
- •17.2.2 Intestinal epithelial cells (IECS)
- •17.2.3 Intestinal junctional complexes
- •17.2.4 Lamina propria
- •17.2.5 Intestinal regulatory T cells
- •17.2.6 Intestinal alkaline phosphatase
- •17.2.7 Antimicrobial peptides
- •17.2.8 Lysozyme
- •17.3 Mechanistic view of factors leading to a leaky gut
- •17.3.1 Gut dysbiosis
- •17.3.2 Mucosal inflammation and oxidative stress
- •17.3.3 TJ disruption
- •17.3.4 Genetics
- •17.3.5 Drugs
- •17.4 Pathological implications of a leaky gut
- •17.5 Natural product improving gut microbial dysbiosis
- •17.5.1 Traditional herbs and polyherbal formulations managing gut micro flora
- •17.5.2 Phytocompounds in the management of intestinal barrier integrity through balancing gut microflora
- •17.6.1 Anti-inflammatory traditional medicine and plant extracts ameliorating intestinal mucosal injury
- •17.6.2 Plant active constituents preventing mucosal injury and oxidative damage
- •17.7 Traditional medicine and natural products upregulating the TJ proteins
- •17.7.1 Traditional medicine and herbal extracts promoting junction protein protection
- •17.7.2 Phytocompounds for junction protein protection
- •17.8 Natural products averting pathological conditions through maintaining intestinal barrier function
- •17.9 Conclusion
- •Keywords
- •References
- •18. Role of Natural Products in the Pharmacotherapy of Osteoporosis
- •18.1 Introduction
- •18.1.1 Effect of traditional chinese medicine (TCM)
- •18.1.2 Effect of malay traditional medicine
- •18.1.3 Antiosteoporotic agents extracted from plant sources
- •18.1.4 Treatment by different pigments
- •18.1.5 Other herbal sources
- •18.1.6 Natural plant-based alkaloids
- •18.1.7 Essential markers involved in bone formation and resorption for osteoporosis treatment
- •18.2 Conclusion
- •Keywords
- •References
- •19. Gel-Based Natural Therapeutics: Potential Alternatives to Traditional Drug Delivery Systems in Aquaculture
- •19.1 INtroduction
- •19.2 DDS
- •19.2.1 Water medication
- •19.3 Oral administration
- •19.3.1 Gavage

413
FIGURE 16.2 Acacia honey.
Source: Photographed by J. Ćirić.
FIGURE 16.3 Nectar in the frame.
Source: Photographed by J. Ćirić.
⏎

414
neochlorogenic, chlorogenic, protocatechuic, caffeic, sinapic, 3,4-di-O-caffeoylquinic,
and protocatechuic acid-O-hexoside acids), and one compound belonged to ellagic acid
(Sawicki et al., 2022).
FIGURE 16.4 Honey in the frame.
Source: Photographed by J. Ćirić.
⏎
Table 16.1 shows the polyphenolic compounds in the different honey samples as
reported by different researchers.
Chlorogenic acid, sinapic acids, gallic acid, ellagic acid, neochlorogenic, and protocatechuic acid were detected in honey in different studies (Yucel et al., 2016; Habryka
et al., 2021; Sawicki et al., 2022). Similarly, in the honey samples, sakuranetin dimer,
caffeic acid, and quercetin were also determined. Similarly, Habryka et al. (2021) detected
phenolic acids and avonoids (kaempferol, chrysin, galangin, and quercetin) in Polish
honey samples. The content number detected is related to the region of honey origin. Also,
previous studies have shown a relationship between the prole of volatile compounds in
honey samples and their geographic area of origin (Yucel et al., 2016; Habryka et al., 2021;
Sawicki et al., 2022).
Table 16.2 depicts the antioxidant activity of honey as determined by the ABTS and
DPPH assays and the PCL method. The order of average antioxidant activity for the
honey was as follows: ABTS > antioxidant capacity of lipid (ACL) (lipophilic antioxidant
capacity) > antioxidant capacity of water (ACW) (hydrophilic antioxidant capacity) >
DPPH. The multioral honey samples were also tested by Sawicki et al. (2022) for the

415
ability to scavenge superoxide anion radicals. The higher hydrophilic antioxidant capacity
of honey has been noticed in comparison to its lipophilic antioxidant capacity. The results
pertaining to honey’s antioxidant activity are consistent with the ndings from similar
studies examining multioral Polish honey (Wesołowska and Dżugan, 2017).
TABLE 16.1 The Polyphenolic Compounds in the Different Honey Samples
Polyphenolic Compound Concentration (µg/g)
Gallic acid 69.2 3.05 217.00
Ellagic acid 6.60 ND ND
Neochlorogenic acid 1.50 ND ND
Chlorogenic acid 13.20 ND ND
Protocatechuic acid 0.20 7.08 70.00
Sakuranetin dimer 4.60 ND ND
Caffeic acid 0.80 79.90 20.00
Rutin ND 56.66 ND
Sinapic acid 1.80 ND ND
Isorhamnetine 3-O-rutinoside
3,4-Di-O-caffeoylquinic acid ND ND ND
Quercetin 3-O-glucuronide
Orientin ND ND ND
Vitexin ND ND ND
Quercetin 2.20 ND ND
Epicatechin ND ND ND
Kaempferol ND 67.10 49.00
Protocatechuic acid-O-hexoside
Pinobanksin ND ND ND
Apigenin ND ND ND
ND ND ND
ND 247.40 40.00
ND ND ND
⏎
ND: not detected.
Source:
Reported by Habryka et al. (2021) and Sawicki et al. (2022).
TABLE 16.2 The Antioxidant Activity and Reducing Potential (FRAP assay) of Honey as Reported by
Different Researchers.
Assay Activities (µmolTrolox/g)
Reference
ACL (lipophilic antioxidant capacity) 1.53 ND
ACW (hydrophilic antioxidants) 4.72 ND
DPPH (1,1-diphenyl-2-picrylhydrazyl) 0.18 0.20
ABTS (2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid)) 15.6 1.78
FRAP (ferric reducing antioxidant power) 35.36 233.9
ND: Not detected.
⏎
Sawicki et al. (2022) Habryka et al. (2021)

416
Honey content of different avonoids originates from pollen, nectar, or propolis (Khalil
et al., 2012). According to Bogdanov et al. (2008), the main avonoids found in honey are
pinocembrin, apigenin, campferol, quercetin, pinobanksin, luteolin, galangin, hesperetin,
and isorhamnetin. Table 16.3 shows the content of phenolic compounds and avonoids
in different honey samples by botanical origin and year of production. Kaškonienė et al.
(2009) show that heather honey contains 201.2 ±5.5 μg/g phenolic compounds. Similar
results were found in the study by Khalil et al. (2011), where the total content of phenolic
compounds in the Tualang honey ranged between 20.99 ± 0.13 μg/g and 42.23 ± 0.64
μg/g. Lianda et al. (2012) found that multioral honey has the highest content of phenolic
compounds as compared to other honey types. The highest avonoid content was identied
in heather honey (44.5 ±3.2 μg/g) followed by buckwheat honey (41.7 ±2.1 μg/g), lime
honey (32.0 ±1.7 μg/g) and rape honey (13.5 ±1.3 μg/g) (Kaškonienė et al., 2009). Cheung
et al. (2019) determined the contents of phenol compounds and avanoids in different
samples of honey. They did not detect avonoids in wolfberry honey, acacia honey, and
loquat honey . The highest total content of phenolic compounds was found in Manuka honey
(250.18 ± 14.39 μg/g). On the other hand, eucalyptus honey showed the highest content of
phenolic compounds (41.65 ± 10.35 μg/g) (Table 16.3).
16.3 BEE BREAD (PERGA)
The bee bread mainly includes pollen, honey, and secretions of bees’ salivary glands
(Figure 16.5 and Figure 16.6). Bee bread is a high source of different compounds, which
exhibit antioxidant activity . The main phenolic compounds in bee bread include quercetin,
kaempferol, myricetin, and luteolin. Bee breads are well known for their nutritional and
medicinal values and have been employed since prehistoric times for different therapeutic
purposes. Bee bread also acts as a functional food in preventing COVID-19, since bee
bread possesses unique criteria as a phytomedicine that could help to protect against, fight,
and alleviate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes
COVID-19 infection (Mohammad et al., 2020).
One of the most important differences between bee bread and bee pollen is that bee
bread is of higher biological value, better digestibility, and chemical composition than
bee pollen (Kieliszek et al., 2018). Honey bees inoculate this mixture (pollen, glandular
secretions, and nectar from crop) with their own microbiota. Inside the beehive, pollen
is stored in the bee wax cells, where fermentation by lactic acid bacteria (Lactobacillus,
Enterococcus, Lactococcus, Leuconostoc, Pediococcus, Streptococcus, Carnobacterium,
Aerococcus, Vagococcus, Oenococcus, Tetragenococcus, and Weissella) and yeasts started
(Ćirić et al., 2022).
During this fermentation process, pollen-added bee enzymes as well as enzymes
produced by the bee-bread microbiome increase its nutritional value. Also, it is tempting
to assume that the diverse bee-bread microbiota produces biological high compounds, thus
enhancing the bioactivity of bee bread (Kieliszek et al., 2018).
Table 16.4 summarizes the phenolic compounds available in bee bread. Phenolic
compounds are dened as secondary plant metabolites with protective mechanisms.

417
TABLE 16.3 Contents of Phenolic Compounds and Flavonoids in Different Honey Samples (Mean ± SD)
Honey’s Origin Phenolic Compounds
Content(μg/g)
Buckwheat 201.60 ± 16.80 41.70 ± 2.10
Heather 201.20 ± 5.50 44.50 ± 3.20
Lime 153.10 ± 5.50 32.00 ± 1.70
Rape 71.70 ± 1.30 13.50 ± 1.30
Tualang honey 1 28.87 ± 0.41 20.52 ± 0.21
Tualang honey 2 20.99 ± 0.13 21.73 ± 0.43
Tualang honey 3 42.23 ± 0.64 25.31 ± 0.37
Gelam honey 20.20 ± 0.56 19.47 ± 0.23
Borneo tropical honey 15.21 ± 0.51 11.52 ± 0.27
Honey “B” 18.59 ± 0.47 15.40 ± 0.49
Manuka honey 52.63 ± 1.21 34.55 ± 0.45
Multifloral 78.20 ± 2.70 ND
Multifloral 42.80 ± 1.90 0.25 ± 0.03
Multifloral 57.20 ± 2.40 1.60 ± 0.16
Multifloral 54.00 ± 2.30 4.27 ± 0.43
Citrus sp.
Citrus sp.
Citrus sp.
Citrus sp.
Citrus sp.
Wolfberry honey 139.30 ± 14.07 ND
Acacia honey 52.60 ± 6.61 ND
Loquat honey 22.90 ± 3.22 ND
Manuka honey 250.18 ± 14.39 14.68 ± 1.20
Beech forest honey 188.13 ± 14.59 22.03 ± 6.03
45° South clover honey 76.36 ± 7.31 5.56 ± 0.55
Eucalyptus honey 175.05 ± 11.60 41.65 ± 10.35
Orange blossom honey 74.57 ± 6.68 17.37 ± 3.91
Wildflower honey 110.46 ± 8.39 33.66 ± 5.74
Black forest honey 135.22 ± 12.49 2.92 ± 0.48
35.70 ± 2.40 0.30 ± 0.03
38.80 ± 3.60 0.28 ± 0.04
53.20 ± 2.90 ND
40.10 ± 2.90 ND
34.00 ± 1.80 0.24 ± 0.01
Flavonoid’s Content
(μg/gRutinEquivalent)
Reference
Kaškonienė et al. (2009)
Khalil et al. (2011)
Lianda et al. (2012)
Cheung et al. (2019)
⏎
They include a large number of phenolic acids, avonoids, proanthocyanidins, and so on
(Mohammad et al., 2020). Several studies have detected the phenolic content of bee bread
(Mayda et al., 2020). In the study of Zuluaga et al. (2015), the total phenolic content of
Columbian bee bread ranged from 2.5 to 13.7 mg GAE/g. Rzepecka-Stojko et al. (2012)
found that the phenolic content of bee pollen was 21.30 mg GAE/g. Čeksteryté et al. (2016)
determined 23.3 mg GAE/g for bee pollen and 21.2 mg GAE/g for bee bread. In general,
kaempferol, myricetin, luteolin, isorhamnetin, and quercetin were the most detected
phenolic compounds in bee bread (Vit et al., 2018). Other phenolic compounds, gallic
acid, caffeic acid, and p-coumaric acid, were also detected in bee bread. It is expected
that phenolic compounds in bee bread vary widely, affected by differences in bee pollen

418
FIGURE 16.5 Bee bread in the frame.
Source: Photographed by J. Ćirić.
⏎
FIGURE 16.6 Bee bread.
Source: Photographed by J. Ćirić.
⏎

419
(botanical origins), season catchment area, and geographical location (Campos et al., 2008).
In general, many studies used two different methods to determine the antioxidant capacity
of extracts: the DPPH and ABTS assays. Both assays have been successfully employed to
estimate the antioxidant activities of bee products.
TABLE 16.4 Polyphenolic Compounds in the Different Bee Pollen Samples
Compound Content (µg/g)
Gallic acid 21.30 3.68
Ellagic acid 2.20 ND
Neochlorogenic acid 0.90 ND
Chlorogenic acid 0.70 ND
Protocatechuic acid 0.10 ND
Sakuranetin dimer ND ND
Caffeic acid ND ND
Rutin 10.00 50.80
Sinapic acid 42.80 ND
Isorhamnetine 3-O-rutinoside
3,4-Di-O-caffeoylquinic acid
Quercetin 3-O-glucuronide
Orientin ND ND
Vitexin ND ND
Quercetin ND ND
Epicatechin 7.20 ND
Kaempferol ND 179.53
Protocatechuic acid-O-hexoside
Pinobanksin 0.70 ND
Apigenin ND ND
5.80 ND
ND ND
7.90 ND
0.20 ND
⏎
16.4 BEE POLLEN
Bee pollen contains essential nutrients. According to Campos et al. (2008), carbohydrates
(13–55%), proteins (10–40%), lipids (1–13%), and fibers (0.3–20%), all contribute to
the composition of bee pollen. In addition, bee pollens are rich in biologically active
compounds like minerals and polyphenols. According to Habryka et al. (2016), bee pollen
is used in apitherapy mainly for its antioxidant and anti-inflammatory effects. Bee pollen
improves blood supply to the nerve tissue, thereby increasing mental performance and
eliminating the state of fatigue. Some studies have also shown a positive effect of bee
pollen on some diseases of the liver, heart, and prostate. The main consumers of bee pollen
are the followers of the health- and environment-conscious lifestyle, as well as the elderly
(Végh et al., 2021) (Figure 16.7).

420
FIGURE 16.7 Bee pollen.
Source: Photographed by J. Ćirić.
⏎
Bee pollen is a very popular bee product that is presently not dened in most national
regulations. In Europe, many studies are conducted, but little data are available from
other continents. According to different studies, bee pollen is characterized by heterogeneous food safety risks and could also be used as a potential environmental bioindicator
(Ćirić et al., 2020).
One of the major secondary metabolites of bee pollen is polyphenols. The total phenolic
content values have been reported to range from 10.8 to 17.64 mg GAE/g for walnut bee
pollen (Cosmulescu et al., 2015), 28.87 mg GAE/g dry weight for chestnut pollen, and
from 16 to 36 mg GAE/g for Turkish pollen. Findings have shown that bee pollen contains
approximately 0.30–3.0% polyphenols (Yıldız et al., 2013).
Rzepecka-Stojko et al. (2015) showed the presence of phenolic acids (gallic, caffeic,
ferulic, 4-hydroxycinnamic, 4-t-p-coumaric, and t-cinnamic acids) and some avonoids
(rutin, myrycithin, quercetin, kaempferol, and isorhamnetin) in bee pollen from Poland.
Also, this study shows that the bee pollen did not contain some compounds detected in the
samples examined in another study (Rzepecka-Stojko et al., 2015). The main compounds
in the bee pollen were sinapic acid (42.80%) followed by gallic acid (21.30%) which are
the indicators of antimicrobial and antioxidant activities.
Many studies presented results that popular bee products have a high antimicrobial
activity. The highest antimicrobial activity was exhibited by bee bread (perga), which

421
inhibited the growth of all the tested microorganisms (Staphylococcus aureus G3, S.
aureus 629G, S. aureus ATCC29213, Listeria monocytogenes 67, L. monocytogenes 74,
L. monocytogenes ATCC1912, Escherichia coli 14169, E. coli 25922, E. coli ATCC8793,
Salmonella typhimurium, S. typhimurium 235, S. typhimurium 63) (Sawicki et al., 2022).
Stronger antimicrobial properties of bee bread could be related to a high contribution of
gallic acid.
16.5 BEE PROPOLIS
Propolis is defined as a mixture of natural substances produced by honey bees from
substances collected from parts of plants and honey bees use propolis to defend the hive
(Figure 16.8). As with other honey bee products, different studies show that propolis
possess very high antimicrobial effects, hence used in medicine. This effect correlated
with the higher contents of polyphenols and terpenoids in propolis. The flavonoid group
includes chrysin, pinocembrin, pinobenchin, apigenin, quercetin, tectochrysin, pinostrobin,
and chrysin (Przybyłek and Karpiński, 2019). Other biological compounds of propolis are
aromatic acids, among which the most often occur are ferulic, cinnamic, caffeic, benzoic,
salicylic, and p
-cumaric acids (Bankova et al., 2000; Kędzia, 2006; Kędzia and Hołderna-
Kędzia, 2017). In addition, propolis also includes phenolic compounds (artepillin C), and
FIGURE 16.8 Bee propolis.
Source: Photographed by J. Ćirić.
⏎

422
terpenes (Bankova et al., 2000; Kędzia and Hołderna-Kędzia, 2017; Kędzia, 2006). Kędzia
(2008) and Toreti et al. (2013) reported micro and macroelements (manganese, iron,
silicium, manganese, zinc, selenium, calcium, potassium, kalium, natrium, and copper)
and vitamins (B1, B2, B6, C, and E) in bee propolis. The presence of these abovementioned
bioactive compounds in various proportions is responsible for antimicrobial properties of
bee propolis (Pamplona-Zomenhan et al., 2011).
16.6 CONCLUSION
The antiviral activities of honey bee products were investigated in many studies against
SARS-CoV-2 infection (COVID-19) during the pandemic. Polyphenols present in bee
pollen and bee bread has promising activity against SARS-CoV-2. Beside polyphenols,
flavonoids and isoflavones have high antiviral activity.
KEYWORDS
• honey
• bee pollen
• bee bread
• functional foods
• antimicrobial effects
REFERENCES
Ajibola, A.; Chamunorwa, J.; Erlwanger, K. H. Nutraceutical values of natural honey and its contribution to
human health and wealth. Nutr. Metab. 2012, 9, 61–73. doi:10.1186/1743-7075-9-61
Ávila, S.; Hornung, P . S.; T eixeira, G. L.; Malunga, L. N.; Apea-Bah, F. B.; Beux, M. R.; Ribani, R. H.; Bioactive
compounds and biological properties of Brazilian stingless bee honey have a strong relationship with the
pollen floral origin. Food Res. Int. 2019, 123, 1–10.
Bankova, V. S.; Castro, D. S. L.; Marcucci, M. C. Propolis: Recent advances in chemistry and plant origin.
Apidologie. 2000, 31, 3–15.
Bogdanov, S.; Jurendic, T.; Sieber, R.; Gallmann P. Honey for nutrition and health: A review. J Am Coll. Nutr.
2008, 27, 677–689. doi:10.1080/ 07315724.2008.10719745
Campos, M. G.; Bogdanov, S.; de Almeida-Muradian, L. B.; Szczesna, T.; Mancebo, Y.; Frigerio, C.; Ferreira,
F. Pollen composition and standardisation of analytical methods. J. Apic. Res. 2008, 47(2), 154–161.0
Čeksteryté, V.; Kurtinaitienė, B. O. G. U. M. I. L. A.; Venskutonis, P. R.; Pukalskas, A.; Kazernavičiūtė, R. I.
T. A.; Balžekas, J. O. N. A. S. Evaluation of antioxidant activity and flavonoid composition in differently
preserved bee products. Czech J. Food Sci. 2016, 34(2), 133–142.
Cheung, Y.; Meenu, M.; Yu, X.; Xu, B. Phenolic acids and flavonoids profiles of commercial honey from
different floral sources and geographic sources. Int. J. Food Prop. 2019, 22(1), 290–308.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
